The Potential of Cell-based Therapy for Diabetes and Diabetes-related Vascular Complications

被引：21

作者：

Liew, Aaron ^{[1
]}

O'Brien, Timothy ^{[1
]}

机构：

[1] Natl Univ Ireland Galway, Natl Ctr Biomed Engn Sci, Regenerat Med Inst REMEDI, Galway, Ireland

来源：

CURRENT DIABETES REPORTS | 2014年 / 14卷 / 03期

关键词：

Cell therapy; Diabetes mellitus; Beta cell replacement; Vascular complications; MESENCHYMAL STEM-CELLS; INSULIN-PRODUCING CELLS; UMBILICAL-CORD BLOOD; MULTIPOTENT STROMAL CELLS; INDUCED PLURIPOTENT; PANCREATIC PROGENITORS; IMMUNE MODULATION; IN-VITRO; TRANSPLANTATION; ISLETS;

D O I：

10.1007/s11892-013-0469-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cell therapy has enormous potential for the treatment of conditions of unmet medical need. Cell therapy may be applied to diabetes mellitus in the context of beta cell replacement or for the treatment of diabetic complications. A large number of cell types including hematopoietic stem cells, mesenchymal stem cells, umbilical cord blood, conditioned lymphocytes, mononuclear cells, or a combination of these cells have been shown to be safe and feasible for the treatment of patients with diabetes mellitus. The first part of this review article will focus on the current perspective of the role of embryonic stem cells and inducible pluripotent stem cells for beta cell replacement and the current clinical data on cell-based therapy for the restoration of normoglycemia. The second part of this review will highlight the therapeutic role of MSCs in islet cells cotransplantation and the management of diabetes related vascular complications.

引用

页数：11

共 98 条

[11]

Dave Shruti D, 2013, BMJ Case Rep, V2013, DOI [10.1136/bcr-2013-009901, 10.1136/bcr-2013-200226]

[12]

Dave Shruti D, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS65, DOI 10.4103/2230-8210.94264

[13] Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel [J].

Davis, Nicolynn E. ;

Beenken-Rothkopf, Liese N. ;

Mirsoian, Annie ;

Kojic, Nikola ;

Kaplan, David L. ;

Barron, Annelise E. ;

Fontaine, Magali J. .

BIOMATERIALS, 2012, 33 (28) :6691-6697

[14] Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model [J].

Dayan, Victor ;

Yannarelli, Gustavo ;

Filomeno, Paola ;

Keating, Armand .

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (05) :516-520

[15]

Dong QY, 2008, CLIN INVEST MED, V31, pE328

[16] Endovenous Administration of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells Prevents Renal Failure in Diabetic Mice [J].

Ezquer, Fernando ;

Ezquer, Marcelo ;

Simon, Valeska ;

Pardo, Fabian ;

Yanez, Alejandro ;

Carpio, Daniel ;

Conget, Paulette .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (11) :1354-1365

[17] Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type I diabetic mice [J].

Ezquer, Fernando E. ;

Ezquer, Marcelo E. ;

Parrau, Daniela B. ;

Carpio, Daniel ;

Yanez, Alejandro J. ;

Conget, Paulette A. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) :631-640

[18]

Fan YJ, 2014, TISSUE ENG PT A, V20, P588, DOI 10.1089/ten.TEA.2013.0219

[19] Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway [J].

Fang, Yan ;

Tian, Xiaohong ;

Bai, Shuling ;

Fan, Jun ;

Hou, Weijian ;

Tong, Hao ;

Li, Dehua .

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 (01) :85-92

[20] Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells [J].

Fujikawa, T ;

Oh, SH ;

Pi, L ;

Hatch, HM ;

Shupe, T ;

Petersen, BE .

AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (06) :1781-1791

← 1 2 3 4 5 6 7 8 9 10 →